Literature DB >> 32158803

A rare case of adult scalp pyoderma gangrenosum with cranial osteolysis.

L Aljohmani1, K Abdul-Jalil1, C deBlacam1, G M Murphy1, J B O'Sullivan1.   

Abstract

Pyoderma gangrenosum (PG) is a rare and painful idiopathic skin condition that has one or more areas of chronic ulceration with well demarcated and undermined borders. Bone osteolysis (the pathological destruction of bone tissue) secondary to PG is a rare phenomenon with limited cases reported in children only. This is the first case report of scalp PG with cranial osteolysis in an 80-year-old adult, with an initial presentation mimicking skin carcinoma. This case highlights the importance of a multidisciplinary team (MDT) meeting discussion, diagnosis of PG by exclusion and the successful treatment of this patient's PG eroding to the bone.
© 2018 The Author(s).

Entities:  

Keywords:  Adult; Cranial osteolysis; Pyoderma gangrenosum; Scalp; Treatment

Year:  2018        PMID: 32158803      PMCID: PMC7061570          DOI: 10.1016/j.jpra.2017.11.006

Source DB:  PubMed          Journal:  JPRAS Open        ISSN: 2352-5878


Case report

An 80-year-old Caucasian male presented to our services with painful scalp ulcerative lesions. The patient was a non-smoker with type-2 diabetes mellitus and hypertension. The patient sustained a traumatic, left parietal scalp wound 2 months prior to presentation. The traumatic scalp wound was managed with regular dressing by the public health nurse but healing was slow and the wound began to deteriorate (Figure 1). At presentation, the patient had also developed a new non-traumatic left frontal scalp ulcer. In the weeks prior to presentation both ulcers had become painful. The scalp lesions were eroding in nature with central ulceration and bleeding and according to the patient had gradually increased in size with associated bleeding of the ulcer. As a neoplastic lesion was suspected, the patient was admitted for oncology workup including radiological staging and punch biopsies for histological diagnosis.
Figure 1

Photograph of scalp PG lesion over time, September 2015.

Photograph of scalp PG lesion over time, September 2015. Following multiple quadrant 4 mm punch biopsies (total of 8 were taken, 4 at each ulcer), results revealed inflammation and chronic ulceration of the tissue with no evidence of malignancy. A computed tomography (CT) of the brain revealed erosion of the outer table cortex only (Figure 2), at both left parietal and left frontal scalp lesions with normal brain parenchyma. After discussion of the case at the skin cancer MDT meeting it was decided to perform investigations for non-cancerous causes of scalp ulceration with input from dermatology and microbiology. Subsequent investigations (Table 1) were all negative and after careful consideration a clinical diagnosis of osteolytic PG of the scalp was made.
Figure 2

CT brain scan of time, correlating with Figure 1 photographic image of PG scalp lesion in September 2015, October 2015 and January 2016.

Table 1

Investigations.

Test groupingTestLevelReference rangeInterpretation
HematologicalU&E(Within normal limits)(Within normal limits)
Albumin/creatinine ratio<0.70.0–2.5 mg/MmolNo diagnosis of micro/macroalbuminuria diagnosis reached
Lactate dehydrogenase (LDH)311208–378 IU/L
ESR111–12 mm/h
FBC(Within normal limits)(Within normal limits)
LFT's(Within normal limits)(Within normal limits)
Iron study(Within normal limits)(Within normal limits)
SerologyRheumatoid arthritis factor (RF)<120–20Unlikely rheumatoid arthritis diagnosis to be reached 90% of rheumatoid is RF positive.
Connective tissue disorder (CTD) screen – includes antibodies for DNA, RNP, SM, Ro, (52 & 60), La and other nuclear antigensNegativeWithin normal rangesConnective tissue disorder unlikely to be diagnosed
Anti nuclear factor (ANF)NegativeWithin normal rangeConnective tissue disorder unlikely to be diagnosed
Myeloperoxidase antibody (MPO)0.10.0–3.5 IU/mlUnlikely vacuities diagnosis to be reached
Proteinase 3 (PR 3)10–2 IU/mlUnlikely vascular damage detected
Serum protein electrophoresis (SPEP)Borderline lowWithin normal rangeNo diagnosis reached
ImmunoglobulinNo diagnosis reached – no contribution was made to any diagnosis to allergy- focused evaluation.
IgG5.86–15 g/l
IgA1.610.7–4 g/l
IgM0.330.5–2.3 g/l
Anti neutrophil cytoplasm AB (ANCA)NegativeWithin normal rangeANCA is positive in 90% of patients with generalized Wegener's granulomatosis or microscopic polyarteritis.
Anti cardiolipin (IgG)20–10 GPLU/mlAnti-phospholipid syndrome unlikely,
Anti cardiolipin (IgM)10–10 MPLU/ ml
Beta 2 glycoprotein IgG30–6 U/ml
Beta 2 glycoprotein10–6 U/ml
MicrobiologicalBlood cultureNo growthUnlikely infective cause detected
Culture swabNo growth
EndoscopyOGDNil findings on scopeUnlikely intra esophageal or intra-colonic cause detected
ColonoscopyNil findings on scope
CT brain scan of time, correlating with Figure 1 photographic image of PG scalp lesion in September 2015, October 2015 and January 2016. Photograph of scalp PG lesion over time, October 2015. Photograph of scalp PG lesion over time, January 2016. Investigations. The patient commenced oral steroids; at post discharge he was followed up closely and his scalp ulcers slowly improved (Figure 3). His steroid regime involved oral prednisolone 40 mg daily for the duration of 3 weeks followed by gradual tapering of dose by 5 mg per week, with the completion of the course at week 12. At one month after the commencement of steroids, his left frontal scalp ulcer had healed and healing of the left parietal scalp ulcer was progressing (Figure 1). The patient reported that pain from both ulcer sites had subsided after the ulcers had healed at 3 months (Figure 4). He had no complication from steroid therapy.
Figure 3

Photograph of scalp PG lesion over time, October 2015.

Figure 4

Photograph of scalp PG lesion over time, January 2016.

Discussion

Osteolytic PG of the scalp is an idiopathic cutaneous disorder. It is characterized by progressive painful ulceration, which causes local destruction of underlying structures. It is a benign lesion, which typically develops post trauma to the area. Histological examination of tissue biopsy shows non-specific inflammation with no malignancy features. PG is a condition diagnosed by exclusion of other underlying systemic disease or inflammatory process that may contribute to the development of skin ulceration or necrosis.2, 3, 4, 5 Approximately 50% of patients diagnosed with PG with skin ulceration or necrosis have an underlying systemic disease. The condition was first described over 85 years ago and an infectious etiology was suspected. Subsequent microbiological investigations failed to elicit any microbial growth to support this concept.7, 8 Several treatments have been described in the literature for cases with known PG including the use of immune-suppressive treatment for a period of 3–6 months depending on response and regular follow-up.5, 9, 10, 11, 12 Surgical excision with split thickness skin-graft reconstruction has also been performed with variable results. PG is a condition where surgical resection may be detrimental due to increase in size of the affected area after resection and poor healing post-operatively. There is also a limited uptake of grafts over the affected area. Surgery has the added disadvantage of potentially initiating a second surgically-triggered PG at the donor site13, 14 or at other sites (for example, the site where the split skin graft is harvested). In the current case study, the patient made a significant recovery 1 month after initiation of steroid therapy with a total regression of the ulcers at 3 months; therefore, further treatment was not required. In this age group, it is prudent to consider preoperative steroid treatment if undergoing surgical treatment9, 15, 16 and discuss the potential of recurrence with the patient. There are two unique features in this case. First, the appearance of the second non-traumatic ulcer (left frontal scalp ulcer) completely separate to the initial ulcer. In addition, it is the first case report of adult scalp osteolytic PG which has been successfully treated with oral steroids.17, 18 The presentation and nature of the lesions created a high-level of suspicion of a malignant origin but effective MDT discussion and sufficient investigations allowed the correct diagnosis to be reached and a more appropriate management plan to be implemented. It is important to take a cautious approach to cancer-mimicking lesions such as those described and to consider that surgical intervention may not lead to the best outcome possible. This case highlighted the importance of MDT meeting discussions, exclusion of malignancy and consideration of other causes of ulcerating scalp lesion such as PG. In summary scalp PG with cranial osteolysis is a rare condition. This case demonstrates that, with an accurate diagnosis, unnecessary surgical procedures can be avoided and a course of oral steroids may provide a safe and effective alternative treatment.

Conflict of interest

None.

Funding

None.
  16 in total

1.  [Malignant pyoderma with cranial osteolysis].

Authors:  F Hali; K Khadir; S Chiheb; H Benchikhi; H Lakhdar
Journal:  Ann Dermatol Venereol       Date:  2009-06-02       Impact factor: 0.777

2.  A large shin ulcer after minor trauma: please do not debride!

Authors:  Kate D Williamson; Nam Q Nguyen
Journal:  Gastroenterology       Date:  2012-08-23       Impact factor: 22.682

Review 3.  Pyoderma gangrenosum: a systematic review.

Authors:  E Cozzani; G Gasparini; A Parodi
Journal:  G Ital Dermatol Venereol       Date:  2014-10       Impact factor: 2.011

Review 4.  Postoperative Pyoderma Gangrenosum: A Clinical Review of Published Cases.

Authors:  Stanislav N Tolkachjov; Aodhnait S Fahy; Felipe B Cerci; David A Wetter; Stephen S Cha; Michael J Camilleri
Journal:  Mayo Clin Proc       Date:  2016-07-31       Impact factor: 7.616

Review 5.  Pyoderma gangrenosum: a review.

Authors:  A Neil Crowson; Martin C Mihm; Cynthia Magro
Journal:  J Cutan Pathol       Date:  2003-02       Impact factor: 1.587

Review 6.  Management of pyoderma gangrenosum.

Authors:  Frank C Powell; Marina O'Kane
Journal:  Dermatol Clin       Date:  2002-04       Impact factor: 3.478

7.  Pyoderma gangrenosum. Abnormal monocyte function corrected in vitro with hydrocortisone.

Authors:  D A Norris; W L Weston; G Thorne; J R Humbert
Journal:  Arch Dermatol       Date:  1978-06

Review 8.  Pyoderma gangrenosum and cranial osteolysis: case report and review of the paediatric literature.

Authors:  C P Samlaska; R A Smith; J B Myers; A G Bottini; D A Person
Journal:  Br J Dermatol       Date:  1995-12       Impact factor: 9.302

Review 9.  Pyoderma gangrenosum: a review.

Authors:  S M Schwaegerle; W F Bergfeld; D Senitzer; R T Tidrick
Journal:  J Am Acad Dermatol       Date:  1988-03       Impact factor: 11.527

Review 10.  Pyoderma gangrenosum--a review.

Authors:  Uwe Wollina
Journal:  Orphanet J Rare Dis       Date:  2007-04-15       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.